title: Should sildenafil be available over the counter?
abstract: BACKGROUND
  This article considers the process of re-classification of prescription drugs from prescription-only medications to over-the-counter (OTC) prescription drugs.
  
  
  METHODS
  The recent change in classification for emergency contraception and simvastatin is explored in detail with similarities and differences being considered for a similar argument to be made for sildenafil.
  
  
  RESULTS
  The benefits for patients, physicians and other healthcare professionals are considered in detail.
  
  
  RESULTS
  We raise concerns about recently developed and existing patient group directions that, although extensive in their assessment, may omit to identify significant contributory factors which would necessitate appropriate medical intervention.
  
  
  CONCLUSIONS
  While the decision for re-classification to OTC would depend on a number of factors, we argue that, with the proviso of proper assessments being made, sildenafil should be made available as an OTC medication.
  
  
  CONCLUSIONS
  The safety and use of OTC medications for erectile dysfunction at a time when many first line prescription agents are reaching generic status.
authors.affiliation: Porterbrook Clinic, Sheffield S11 9BF, UK. k.r.wylie@sheffield.ac.uk
authors.forename: Naomi
authors.initials: N
authors.lastname: Rubin
authors.forename: Kevan
authors.initials: K
authors.lastname: Wylie
mesh_terms: D003257:Consumer Product Safety; D007172:Erectile Dysfunction / Q000188:drug therapy* / Q000523:psychology; D005260:Female; D006801:Humans; D008297:Male; D004366:Nonprescription Drugs / Q000145:classification / Q000600:supply & distribution*; D010593:Pharmaceutical Services; D010726:Phosphodiesterase Inhibitors / Q000600:supply & distribution*; D010879:Piperazines / Q000145:classification / Q000600:supply & distribution*; D017410:Practice Guidelines as Topic; D055553:Prescription Drugs; D011687:Purines / Q000145:classification / Q000600:supply & distribution; D000068677:Sildenafil Citrate; D013450:Sulfones / Q000145:classification / Q000600:supply & distribution*
chemical_list: D004366:Nonprescription Drugs; D010726:Phosphodiesterase Inhibitors; D010879:Piperazines; D055553:Prescription Drugs; D011687:Purines; D013450:Sulfones; D000068677:Sildenafil Citrate